Patients with cirrhosis who have coronary artery disease treated with cardiac stents have high rates of gastrointestinal bleeding, but no increased mortality

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Alimentary Pharmacology and Therapeutics

• Publication date

  2017-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/apt.14121PMID 28488370
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Heart Disease and Stroke Statistics—2016 Update: A Report From the American Heart Association

  2016cited by this paper
• Coronary Artery Stents and Antiplatelet Therapy in Patients With Cirrhosis

  2012cited by this paper
• Feasibility and safety of percutaneous coronary intervention in patients with end‐stage liver disease referred for liver transplantation

  2011cited by this paper
• Cardiac catheterization in patients with end‐stage liver disease: Safety and outcomes

  2011cited by this paper
• Incidence, Predictors, and Outcomes of Gastrointestinal Bleeding in Patients on Dual Antiplatelet Therapy With Aspirin and Clopidogrel

  2011cited by this paper
• Presence of coronary plaques in patients with nonalcoholic fatty liver disease.

  2010cited by this paper
• Liver enzymes, nonalcoholic fatty liver disease, and incident cardiovascular disease: A narrative review and clinical perspective of prospective data

  2010cited by this paper
• Coronary Artery Disease in Patients with Liver Cirrhosis

  2010cited by this paper
• The Management of Antiplatelet Therapy in Patients With Coronary Stents Undergoing Noncardiac Surgery

  2010cited by this paper
• Safety of cardiac catheterization in patients with end-stage liver disease awaiting liver transplantation.

  2009cited by this paper
• Upper gastrointestinal bleeding in patients receiving dual antiplatelet therapy after coronary stenting.

  2009cited by this paper
• Clinical and pathologic risk factors for atherosclerosis in cirrhosis: a comparison between NASH-related cirrhosis and cirrhosis due to other aetiologies.

  2008cited by this paper
• Hemodynamic Evaluation Before Liver Transplantation: Insights Into the Portal Hypertensive Syndrome

  2007cited by this paper
• Cardiac hemodynamic and coronary angiographic characteristics of patients being evaluated for liver transplantation.

  2006cited by this paper
• Low bleeding risk from cardiac catheterization in patients with advanced liver disease

  2005cited by this paper
• Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial.

  2003cited by this paper
• Detection and treatment of coronary artery disease in liver transplant candidates

  2001cited by this paper
• EFFECTS OF CLOPIDOGREL IN ADDITION TO ASPIRIN IN PATIENTS WITH ACUTE CORONARY SYNDROMES WITHOUT ST-SEGMENT ELEVATION

  2001cited by this paper
• Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation.

  2001cited by this paper
• Dobutamine stress echocardiography for preoperative cardiac risk stratification in patients undergoing orthotopic liver transplantation.

  1998cited by this paper
• Two-dimensional and dobutamine stress echocardiography in the preoperative assessment of patients with end-stage liver disease prior to orthotopic liver transplantation.

  1996cited by this paper
• The prevalence of coronary artery disease in liver transplant candidates over age 50.

  1995cited by this paper
• Candidates

  1982cited by this paper
• Atherosclerosis and cirrhosis of the liver.

  1976cited by this paper
• The low incidence of myocardial infarction in patients with portal cirrhosis of the liver: A review of 639 cases of cirrhosis of the liver from 17,731 autopsies.

  1960cited by this paper
• THE SEVERITY OF AORTIC ARTERIOSCLEROSIS IN CERTAIN DISEASES: A NECROPSY STUDY

  1955cited by this paper

• Management of Liver Cirrhosis in Percutaneous and Surgical Cardiac Interventions.

  2026cites this paper
• Aspirin reduces short-term mortality risk in critically ill patients with liver cirrhosis: a propensity-score matched retrospective analysis using the MIMIC-IV database

  2025cites this paper
• CardioHepatology: Exploring the Interplay Between Cirrhosis, Cirrhotic Cardiomyopathy, Coronary Artery Disease, and Liver Transplantation.

  2025cites this paper
• The Risk of Gastrointestinal Bleeding with Dual Antiplatelet Therapy in Cirrhotics Undergoing Liver Transplant Evaluation.

  2025cites this paper
• A Risk Stratification Score for Predicting First Episode of Upper Gastrointestinal Bleeding in Patients With Cirrhosis.

  2025cites this paper
• Performance Status of Older Adults Who Developed Acute Coronary Syndrome during Hospitalization for Noncardiac Illness and Their Clinical Outcome: A Prospective Observational Study

  2025cites this paper
• Risk and management of cardiac disease in kidney and liver transplant recipients

  2025cites this paper
• Coronary Intervention Outcomes in Patients with Liver Cirrhosis

  2025cites this paper
• Clinical outcome of older adults developing acute coronary syndrome during hospitalization for noncardiac illness: A prospective observational study

  2025cites this paper
• Depression among older adults who developed acute coronary syndrome (ACS) during hospitalization for non-cardiac illness: A prospective observational study

  2024influential citation
• Frailty among Older Adults Who Developed Acute Coronary Syndrome during Hospitalization for Noncardiac Illness and Their Outcome: A Prospective Observational Study

  2024cites this paper
• Management of the liver transplant candidate with high cardiac risk: Multidisciplinary best practices and recommendations

  2024cites this paper
• Diseases of the gastrointestinal tract coronary heart disease: relationships and mutual influences

  2023cites this paper
• Optimizing cardiac status in the preliver transplant candidate

  2023cites this paper
• Using noninvasive clinical parameters to predict mortality and morbidity after cardiac interventions in patients with cirrhosis: A systematic review

  2023cites this paper
• Improving Management of Portal Hypertension: The Potential Benefit of Non-Etiological Therapies in Cirrhosis

  2023cites this paper
• Emerging Evidence on Coronary Heart Disease Screening in Kidney and Liver Transplantation Candidates: A Scientific Statement From the American Heart Association.

  2022cites this paper
• Exposure to Proton Pump Inhibitors and the Risk of Incident Asthma in Patients with Coronary Artery Diseases: A Population-Based Cohort Study

  2022cites this paper
• Ischemic Heart Disease and Liver Cirrhosis: Adding Insult to Injury

  2022cites this paper
• Rational hemostatic management in cirrhosis: from old paradigms to new clinical challenges

  2022cites this paper
• Review article: the safety of anticoagulants and antiplatelet agents in patients with cirrhosis

  2022influential citation
• Survival outcomes of patients with concomitant acute variceal bleeding and acute coronary syndrome, and the role of antiplatelet agents: an institutional experience from a lower middle-income Country

  2022influential citation
• Bleeding and thrombosis in cirrhosis.

  2022cites this paper
• The Association Between Proton Pump Inhibitors and Incident Asthma in Patients with Coronary Artery Disease: A Population-Based Cohort Study

  2021cites this paper
• Antiplatelet drugs and liver fibrosis

  2021cites this paper
• From Coronaries to Cirrhosis: The Role of Percutaneous Coronary Intervention and Dual Antiplatelet Therapy in End-Stage Liver Disease

  2021cites this paper
• Safety and efficacy of dual antiplatelet therapy after percutaneous coronary interventions in patients with end-stage liver disease

  2021cites this paper
• Management of Acute Coronary Syndrome in Patients with Liver Cirrhosis

  2021cites this paper
• Impact of Cirrhosis on 90-Day Outcomes After Percutaneous Coronary Intervention.

  2020cites this paper
• Dual anti-platelet therapy following percutaneous coronary intervention in a population of patients with thrombocytopenia at baseline: a meta-analysis

  2020cites this paper
• Impact Of Cirrhosis On 90-Day Outcomes After Percutaneous Coronary Intervention (from A Nationwide Database).

  2020cites this paper
• Selection for Liver Transplantation: Indications and Evaluation

  2020cites this paper
• Defining High Bleeding Risk in Patients Undergoing Percutaneous Coronary Intervention

  2020cites this paper
• In-Hospital Outcomes of Patients with Acute Decompensated Heart Failure and Cirrhosis: An Analysis of the National Inpatient Sample

  2020cites this paper
• Defining High Bleeding Risk in Patients Undergoing Percutaneous Coronary Intervention

  2019cites this paper
• Anticoagulation Therapy in Patients with Liver Cirrhosis is Associated With an Increased Risk of Variceal Hemorrhage.

  2019cites this paper
• AGA Clinical Practice Update on Surgical Risk Assessment and Perioperative Management in Cirrhosis: Expert Review

  2019cites this paper
• OP-EHEA190379 2632..2653

  2019cites this paper
• Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the Academic Research Consortium for High Bleeding Risk

  2019cites this paper
• Dual antiplatelet therapy in patients with cirrhosis and acute myocardial infarction – A 13-year nationwide cohort study

  2019cites this paper
• Letter: bleeding in cirrhotics receiving coronary stenting and antiplatelet therapy

  2017influential citation
• Letter: the treatment of coronary artery disease in cirrhotics needs more thinking—author's reply

  2017cites this paper
• Letter: Helicobacter pylori in lean and obese patients with non‐alcoholic fatty liver disease

  2017cites this paper
• Letter: the treatment of coronary artery disease in cirrhotics needs more thinking

  2017cites this paper
• Pretransplant coronary artery disease is a predictor for myocardial infarction and cardiac death after liver transplantation.

  2017cites this paper
• Letter: bleeding in cirrhotics receiving coronary stenting and antiplatelet therapy – author's reply

  2017cites this paper